Health Claims Law Includes Effect On Existing Disease – Saw Palmetto Appeal
This article was originally published in The Tan Sheet
Executive Summary
A Washington, D.C. federal court committed a "plain and reversible error" when it upheld FDA's decision to deny a health claim linking saw palmetto extract to the treatment of benign prostatic hyperplasia symptoms, according to an appellate brief filed May 16